BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9654337)

  • 1. Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats.
    Cass WA; Manning MW; Dugan MT
    Neurosci Lett; 1998 Jun; 248(3):175-8. PubMed ID: 9654337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW; Bailey SL
    Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW
    J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine.
    Cass WA
    J Neurochem; 2000 Mar; 74(3):1079-85. PubMed ID: 10693939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
    Cass WA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum.
    Robinson TE; Yew J; Paulson PE; Camp DM
    Neurosci Lett; 1990 Mar; 110(1-2):193-8. PubMed ID: 1691471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.
    Cass WA; Harned ME; Peters LE; Nath A; Maragos WF
    Brain Res; 2003 Sep; 984(1-2):133-42. PubMed ID: 12932847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
    Gerhardt GA; Maloney RE
    Brain Res; 1999 Jan; 816(1):68-77. PubMed ID: 9878690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
    Baldwin HA; Colado MI; Murray TK; De Souza RJ; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):590-6. PubMed ID: 8467354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
    Cass WA; Walker DJ; Manning MW
    Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol protects against reductions in striatal serotonin in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Peters LE
    Neurochem Int; 2023 Oct; 169():105590. PubMed ID: 37536650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo microdialysis studies of age-related alterations in potassium-evoked overflow of dopamine in the dorsal striatum of Fischer 344 rats.
    Stanford JA; Giardina K; Gerhardt GA
    Int J Dev Neurosci; 2000; 18(4-5):411-6. PubMed ID: 10817924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593.
    El Daly E; Chefer V; Sandill S; Shippenberg TS
    J Neurochem; 2000 Apr; 74(4):1553-62. PubMed ID: 10737612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1997 Aug; 767(1):34-44. PubMed ID: 9365013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
    Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats.
    Cass WA; Peters LE; Fletcher AM; Yurek DM
    Neurochem Res; 2014 Aug; 39(8):1467-76. PubMed ID: 24858239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic stress augments the long-term and acute effects of methamphetamine.
    Matuszewich L; Yamamoto BK
    Neuroscience; 2004; 124(3):637-46. PubMed ID: 14980734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat.
    Kametani H; Iijima S; Spangler EL; Ingram DK; Joseph JA
    Neurobiol Aging; 1995; 16(4):639-46. PubMed ID: 8544915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.
    Cass WA
    J Neurosci; 1996 Dec; 16(24):8132-9. PubMed ID: 8987838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
    Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
    Int J Dev Neurosci; 2000 Oct; 18(6):521-30. PubMed ID: 10884597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.